Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. NATCO Pharma Limited
FDA Inspection
•NATCO Pharma Limited•June 6, 2019

NATCO Pharma Limited – FDA Inspection, Jun 6, 2019

Record Details

This FDA Inspection record concerns NATCO Pharma Limited, with an inspection on June 6, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
NATCO Pharma Limited
Inspection Date
June 6, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Marcellinus D. Dordunoo (FDA Associated Person)
  • Patric C. Klotzbuecher (Issuing Officer)
View Company Profile

ID · ea855f48-56a5-4020-95b4-2e58b1a8caf2

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1095772
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

Other FDA inspections of NATCO Pharma Limited

7
DateClassificationOfficeProject area
June 19, 2025VAIOffice of Inspections and InvestigationsDrug Quality Assurance
October 18, 2023Not classifiedOffice of Inspections and InvestigationsDrug Quality Assurance
June 24, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 24, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 23, 2014VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for NATCO Pharma Limited
  • FDA Inspection 1273711 - 2025-06-19
  • FDA Inspection 1220533 - 2023-10-18
  • FDA Inspection 1137171 - 2019-06-24
  • FDA Inspection 1011854 - 2017-01-24
  • FDA Inspection 880454 - 2014-05-23

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore NATCO Pharma Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.